A multicenter retrospective experience of infliximab in Crohn's disease patients: infusion reaction rates and treatment persistency.
Keshavarzian A, Mayer L, Salzberg B, Garone M, Finkelstein W, Cappa J, Brand M, Hain J, Zelinger D, Hegedus R, Diamond RH, Campbell U, Lane C, Stang P, Watson J, Cominelli F.
Keshavarzian A, et al.
Gastroenterol Hepatol (N Y). 2007 May;3(5):381-90.
Gastroenterol Hepatol (N Y). 2007.
PMID: 21960854
Free PMC article.